{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:36Z","timestamp":1792083576360,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.htct.2026.108554","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:29:37Z","timestamp":1792081777000},"page":"108554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between myeloproliferative diseases and T cell acute lymphoblastic leukemia: a case report and literature review"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-1187","authenticated-orcid":false,"given":"Viktoria","family":"Weihermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Vieira Rodrigues","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira DRP","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-0778","authenticated-orcid":false,"given":"Luciana","family":"Nardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-1428","authenticated-orcid":false,"given":"Israel","family":"Bendit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3181","authenticated-orcid":false,"given":"Wellington Fernandes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.htct.2026.108554_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.2019000943","article-title":"Leukemia secondary to myeloproliferative neoplasms","volume":"136","author":"Dunbar","year":"2020","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.htct.2026.108554_bib0002","article-title":"JAK2 V617F acute lymphoblastic leukemia secondary to myeloproliferative neoplasms (MPNs) or after lenalidomide exposure: case report and review of the literature","volume":"17","author":"Alhuraiji","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.htct.2026.108554_bib0003","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3332\/ecancer.2020.1011","article-title":"The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases","volume":"14","author":"Burns","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"11","key":"10.1016\/j.htct.2026.108554_bib0004","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.htct.2026.108554_bib0005","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.htct.2026.108554_bib0006","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2026.108554_bib0007","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/16078454.2022.2052602","article-title":"Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation","volume":"27","author":"Silva","year":"2022","journal-title":"Hematology"},{"issue":"8","key":"10.1016\/j.htct.2026.108554_bib0008","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/cancers14081873","article-title":"Early T-cell precursor all and beyond: immature and ambiguous lineage T-ALL subsets","volume":"14","author":"Genesc\u00e0","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.htct.2026.108554_bib0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4274\/tjh.galenos.2023.2023.0139","article-title":"Emerging necessity of myeloid mutational analysis in early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL)","volume":"40","author":"Tariq","year":"2023","journal-title":"Turk J Haematol"},{"issue":"11","key":"10.1016\/j.htct.2026.108554_bib0010","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/biomedicines9111621","article-title":"T-cell acute lymphoblastic leukemia-current concepts in molecular biology and management","volume":"9","author":"Shiraz","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.htct.2026.108554_bib0011","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1590\/S1415-47572008000300006","article-title":"Infrequent V617F mutation of the JAK2 gene in myeloid leukemia and its absence in lymphoid malignancies in Japan","volume":"31","author":"Mori","year":"2008","journal-title":"Genet Mol Biol"},{"issue":"16","key":"10.1016\/j.htct.2026.108554_bib0012","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.htct.2026.108554_bib0013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-021-01068-4","article-title":"Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL","volume":"14","author":"Simonin","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.htct.2026.108554_bib0014","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1016\/S2352-3026(25)00284-4","article-title":"Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial","volume":"12","author":"Cao","year":"2025","journal-title":"Lancet Haematol"},{"issue":"18","key":"10.1016\/j.htct.2026.108554_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810957","article-title":"The emerging role of venetoclax-based treatments in acute lymphoblastic leukemia","volume":"23","author":"Aumann","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.htct.2026.108554_bib0016","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000310","article-title":"Ruxolitinib synergizes with dexamethasone for the treatment of T-cell acute lymphoblastic leukemia","volume":"3","author":"Verbeke","year":"2019","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.htct.2026.108554_bib0017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jha2.143","article-title":"Ruxolitinib is effective in the treatment of a patient with refractory T-ALL","volume":"2","author":"Jaramillo","year":"2020","journal-title":"EJHaem"},{"key":"10.1016\/j.htct.2026.108554_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2023.1134837","article-title":"Case report: sustained complete remission with ivosidenib in a patient with relapsed, IDH1-mutated acute leukemia","volume":"2","author":"Sahasrabudhe","year":"2023","journal-title":"Front Hematol"},{"key":"10.1016\/j.htct.2026.108554_bib0019","author":"Epstein-Peterson"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926023011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926023011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:29:39Z","timestamp":1792081779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926023011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S2531137926023011"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.108554","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between myeloproliferative diseases and T cell acute lymphoblastic leukemia: a case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.108554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"108554"}}